CGEN FY 2024 Earnings — Compugen Ltd. Revenue & Financial Results | Market Cap Arena

CGENCompugen Ltd.

$202M

FY 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$28M-16.7% YoY

Gross Profit

$20M71.5% margin

Operating Income

-$15M-53.4% margin

Net Income

-$14M-51.1% margin

EPS (Diluted)

$-0.16

Cash Flow

Operating Cash Flow

$50M

Free Cash Flow

$49M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$115M

Total Liabilities

$60M

Stockholders' Equity

$55M

Cash & Equivalents

$18M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$28M	$33M	-16.7%
Gross Profit	$20M	$31M	-36.6%
Operating Income	-$15M	-$13M	-14.6%
Net Income	-$14M	-$19M	+24.1%